Abcellera Biologics/$ABCL
About Abcellera Biologics
Ticker
Industry
Headquarters
Employees
ABCL Metrics
$886M
-
-$0.61
0.35
-
Price and volume
Market cap
$886M
Beta
0.35
52-week high
$5.62
52-week low
$2.34
Average daily volume
2.9M
Financial strength
Current ratio
9.336
Quick ratio
8.477
Long term debt to equity
6.147
Total debt to equity
6.623
Management effectiveness
Return on assets (TTM)
-13.26%
Return on equity (TTM)
-15.55%
Valuation
Price to revenue (TTM)
26.672
Price to book
0.82
Price to tangible book (TTM)
0.91
Price to free cash flow (TTM)
-4.442
Growth
Revenue change (TTM)
-34.59%
Earnings per share change (TTM)
35.86%
3-year revenue growth (CAGR)
-57.96%
3-year earnings per share growth (CAGR)
-1.81%
What the Analysts think about ABCL
Analyst Ratings
ABCL Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
ABCL Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
ABCL News
FAQs
What’s the current market cap for Abcellera Biologics stock?
What is the P/E ratio for Abcellera Biologics stock?
Does Abcellera Biologics stock pay dividends?
No, Abcellera Biologics (ABCL) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Abcellera Biologics dividend payment date?
Abcellera Biologics (ABCL) stock does not pay dividends to its shareholders.
What is the beta indicator for Abcellera Biologics?
Abcellera Biologics (ABCL) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.